ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmaceutical Contract Manufacture Organization Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-30H5835
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharmaceutical Contract Manufacture Organization Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Pharmaceutical Contract Manufacture Organization Market Research Report 2025

Code: QYRE-Auto-30H5835
Report
September 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Lonza
Boehringer Ingelheim
Catalent
Baxter
AbbVie
Pfizer Inc
Evonik
Fareva Group
Aenova
ALMAC
Delpharm
Recipharm
Aesica
Nipro Corporation
Daito Pharmaceutical
Teva API
Esteve Quimica
Euticals
Zhejiang Hisun Pharmaceuticals

Pharmaceutical Contract Manufacture Organization Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Pharmaceutical Contract Manufacture Organization Market

Pharmaceutical Contract Manufacture Organization Market

The global market for Pharmaceutical Contract Manufacture Organization was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Contract Manufacture Organization, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Contract Manufacture Organization.
The Pharmaceutical Contract Manufacture Organization market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical Contract Manufacture Organization market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Contract Manufacture Organization companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Pharmaceutical Contract Manufacture Organization Market Report

Report Metric Details
Report Name Pharmaceutical Contract Manufacture Organization Market
CAGR 5%
Segment by Type
  • Active Pharmaceutical Ingredients (APIs)
  • Finished Dose Formulations (FDFs)
Segment by Application
  • Specialty/Midsize
  • Generics
  • Big Pharma
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Lonza, Boehringer Ingelheim, Catalent, Baxter, AbbVie, Pfizer, Evonik, Fareva group, Aenova, Almac, Delpharm, Recipharm, Aesica, NIPRO CORPORATION, Daito Pharmaceutical, Teva API, Esteve Quimica, Euticals, Zhejiang Hisun Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Pharmaceutical Contract Manufacture Organization company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pharmaceutical Contract Manufacture Organization Market report?

Ans: The main players in the Pharmaceutical Contract Manufacture Organization Market are Lonza, Boehringer Ingelheim, Catalent, Baxter, AbbVie, Pfizer, Evonik, Fareva group, Aenova, Almac, Delpharm, Recipharm, Aesica, NIPRO CORPORATION, Daito Pharmaceutical, Teva API, Esteve Quimica, Euticals, Zhejiang Hisun Pharmaceuticals

What are the Application segmentation covered in the Pharmaceutical Contract Manufacture Organization Market report?

Ans: The Applications covered in the Pharmaceutical Contract Manufacture Organization Market report are Specialty/Midsize, Generics, Big Pharma, Others

What are the Type segmentation covered in the Pharmaceutical Contract Manufacture Organization Market report?

Ans: The Types covered in the Pharmaceutical Contract Manufacture Organization Market report are Active Pharmaceutical Ingredients (APIs), Finished Dose Formulations (FDFs)

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Contract Manufacture Organization Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Active Pharmaceutical Ingredients (APIs)
1.2.3 Finished Dose Formulations (FDFs)
1.3 Market by Application
1.3.1 Global Pharmaceutical Contract Manufacture Organization Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Specialty/Midsize
1.3.3 Generics
1.3.4 Big Pharma
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Contract Manufacture Organization Market Perspective (2020-2031)
2.2 Global Pharmaceutical Contract Manufacture Organization Growth Trends by Region
2.2.1 Global Pharmaceutical Contract Manufacture Organization Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pharmaceutical Contract Manufacture Organization Historic Market Size by Region (2020-2025)
2.2.3 Pharmaceutical Contract Manufacture Organization Forecasted Market Size by Region (2026-2031)
2.3 Pharmaceutical Contract Manufacture Organization Market Dynamics
2.3.1 Pharmaceutical Contract Manufacture Organization Industry Trends
2.3.2 Pharmaceutical Contract Manufacture Organization Market Drivers
2.3.3 Pharmaceutical Contract Manufacture Organization Market Challenges
2.3.4 Pharmaceutical Contract Manufacture Organization Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Contract Manufacture Organization Players by Revenue
3.1.1 Global Top Pharmaceutical Contract Manufacture Organization Players by Revenue (2020-2025)
3.1.2 Global Pharmaceutical Contract Manufacture Organization Revenue Market Share by Players (2020-2025)
3.2 Global Pharmaceutical Contract Manufacture Organization Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pharmaceutical Contract Manufacture Organization Revenue
3.4 Global Pharmaceutical Contract Manufacture Organization Market Concentration Ratio
3.4.1 Global Pharmaceutical Contract Manufacture Organization Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Contract Manufacture Organization Revenue in 2024
3.5 Global Key Players of Pharmaceutical Contract Manufacture Organization Head office and Area Served
3.6 Global Key Players of Pharmaceutical Contract Manufacture Organization, Product and Application
3.7 Global Key Players of Pharmaceutical Contract Manufacture Organization, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Contract Manufacture Organization Breakdown Data by Type
4.1 Global Pharmaceutical Contract Manufacture Organization Historic Market Size by Type (2020-2025)
4.2 Global Pharmaceutical Contract Manufacture Organization Forecasted Market Size by Type (2026-2031)
5 Pharmaceutical Contract Manufacture Organization Breakdown Data by Application
5.1 Global Pharmaceutical Contract Manufacture Organization Historic Market Size by Application (2020-2025)
5.2 Global Pharmaceutical Contract Manufacture Organization Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pharmaceutical Contract Manufacture Organization Market Size (2020-2031)
6.2 North America Pharmaceutical Contract Manufacture Organization Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pharmaceutical Contract Manufacture Organization Market Size by Country (2020-2025)
6.4 North America Pharmaceutical Contract Manufacture Organization Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical Contract Manufacture Organization Market Size (2020-2031)
7.2 Europe Pharmaceutical Contract Manufacture Organization Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pharmaceutical Contract Manufacture Organization Market Size by Country (2020-2025)
7.4 Europe Pharmaceutical Contract Manufacture Organization Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Contract Manufacture Organization Market Size (2020-2031)
8.2 Asia-Pacific Pharmaceutical Contract Manufacture Organization Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pharmaceutical Contract Manufacture Organization Market Size by Region (2020-2025)
8.4 Asia-Pacific Pharmaceutical Contract Manufacture Organization Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical Contract Manufacture Organization Market Size (2020-2031)
9.2 Latin America Pharmaceutical Contract Manufacture Organization Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pharmaceutical Contract Manufacture Organization Market Size by Country (2020-2025)
9.4 Latin America Pharmaceutical Contract Manufacture Organization Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Contract Manufacture Organization Market Size (2020-2031)
10.2 Middle East & Africa Pharmaceutical Contract Manufacture Organization Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pharmaceutical Contract Manufacture Organization Market Size by Country (2020-2025)
10.4 Middle East & Africa Pharmaceutical Contract Manufacture Organization Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Pharmaceutical Contract Manufacture Organization Introduction
11.1.4 Lonza Revenue in Pharmaceutical Contract Manufacture Organization Business (2020-2025)
11.1.5 Lonza Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Pharmaceutical Contract Manufacture Organization Introduction
11.2.4 Boehringer Ingelheim Revenue in Pharmaceutical Contract Manufacture Organization Business (2020-2025)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Catalent
11.3.1 Catalent Company Details
11.3.2 Catalent Business Overview
11.3.3 Catalent Pharmaceutical Contract Manufacture Organization Introduction
11.3.4 Catalent Revenue in Pharmaceutical Contract Manufacture Organization Business (2020-2025)
11.3.5 Catalent Recent Development
11.4 Baxter
11.4.1 Baxter Company Details
11.4.2 Baxter Business Overview
11.4.3 Baxter Pharmaceutical Contract Manufacture Organization Introduction
11.4.4 Baxter Revenue in Pharmaceutical Contract Manufacture Organization Business (2020-2025)
11.4.5 Baxter Recent Development
11.5 AbbVie
11.5.1 AbbVie Company Details
11.5.2 AbbVie Business Overview
11.5.3 AbbVie Pharmaceutical Contract Manufacture Organization Introduction
11.5.4 AbbVie Revenue in Pharmaceutical Contract Manufacture Organization Business (2020-2025)
11.5.5 AbbVie Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Pharmaceutical Contract Manufacture Organization Introduction
11.6.4 Pfizer Revenue in Pharmaceutical Contract Manufacture Organization Business (2020-2025)
11.6.5 Pfizer Recent Development
11.7 Evonik
11.7.1 Evonik Company Details
11.7.2 Evonik Business Overview
11.7.3 Evonik Pharmaceutical Contract Manufacture Organization Introduction
11.7.4 Evonik Revenue in Pharmaceutical Contract Manufacture Organization Business (2020-2025)
11.7.5 Evonik Recent Development
11.8 Fareva group
11.8.1 Fareva group Company Details
11.8.2 Fareva group Business Overview
11.8.3 Fareva group Pharmaceutical Contract Manufacture Organization Introduction
11.8.4 Fareva group Revenue in Pharmaceutical Contract Manufacture Organization Business (2020-2025)
11.8.5 Fareva group Recent Development
11.9 Aenova
11.9.1 Aenova Company Details
11.9.2 Aenova Business Overview
11.9.3 Aenova Pharmaceutical Contract Manufacture Organization Introduction
11.9.4 Aenova Revenue in Pharmaceutical Contract Manufacture Organization Business (2020-2025)
11.9.5 Aenova Recent Development
11.10 Almac
11.10.1 Almac Company Details
11.10.2 Almac Business Overview
11.10.3 Almac Pharmaceutical Contract Manufacture Organization Introduction
11.10.4 Almac Revenue in Pharmaceutical Contract Manufacture Organization Business (2020-2025)
11.10.5 Almac Recent Development
11.11 Delpharm
11.11.1 Delpharm Company Details
11.11.2 Delpharm Business Overview
11.11.3 Delpharm Pharmaceutical Contract Manufacture Organization Introduction
11.11.4 Delpharm Revenue in Pharmaceutical Contract Manufacture Organization Business (2020-2025)
11.11.5 Delpharm Recent Development
11.12 Recipharm
11.12.1 Recipharm Company Details
11.12.2 Recipharm Business Overview
11.12.3 Recipharm Pharmaceutical Contract Manufacture Organization Introduction
11.12.4 Recipharm Revenue in Pharmaceutical Contract Manufacture Organization Business (2020-2025)
11.12.5 Recipharm Recent Development
11.13 Aesica
11.13.1 Aesica Company Details
11.13.2 Aesica Business Overview
11.13.3 Aesica Pharmaceutical Contract Manufacture Organization Introduction
11.13.4 Aesica Revenue in Pharmaceutical Contract Manufacture Organization Business (2020-2025)
11.13.5 Aesica Recent Development
11.14 NIPRO CORPORATION
11.14.1 NIPRO CORPORATION Company Details
11.14.2 NIPRO CORPORATION Business Overview
11.14.3 NIPRO CORPORATION Pharmaceutical Contract Manufacture Organization Introduction
11.14.4 NIPRO CORPORATION Revenue in Pharmaceutical Contract Manufacture Organization Business (2020-2025)
11.14.5 NIPRO CORPORATION Recent Development
11.15 Daito Pharmaceutical
11.15.1 Daito Pharmaceutical Company Details
11.15.2 Daito Pharmaceutical Business Overview
11.15.3 Daito Pharmaceutical Pharmaceutical Contract Manufacture Organization Introduction
11.15.4 Daito Pharmaceutical Revenue in Pharmaceutical Contract Manufacture Organization Business (2020-2025)
11.15.5 Daito Pharmaceutical Recent Development
11.16 Teva API
11.16.1 Teva API Company Details
11.16.2 Teva API Business Overview
11.16.3 Teva API Pharmaceutical Contract Manufacture Organization Introduction
11.16.4 Teva API Revenue in Pharmaceutical Contract Manufacture Organization Business (2020-2025)
11.16.5 Teva API Recent Development
11.17 Esteve Quimica
11.17.1 Esteve Quimica Company Details
11.17.2 Esteve Quimica Business Overview
11.17.3 Esteve Quimica Pharmaceutical Contract Manufacture Organization Introduction
11.17.4 Esteve Quimica Revenue in Pharmaceutical Contract Manufacture Organization Business (2020-2025)
11.17.5 Esteve Quimica Recent Development
11.18 Euticals
11.18.1 Euticals Company Details
11.18.2 Euticals Business Overview
11.18.3 Euticals Pharmaceutical Contract Manufacture Organization Introduction
11.18.4 Euticals Revenue in Pharmaceutical Contract Manufacture Organization Business (2020-2025)
11.18.5 Euticals Recent Development
11.19 Zhejiang Hisun Pharmaceuticals
11.19.1 Zhejiang Hisun Pharmaceuticals Company Details
11.19.2 Zhejiang Hisun Pharmaceuticals Business Overview
11.19.3 Zhejiang Hisun Pharmaceuticals Pharmaceutical Contract Manufacture Organization Introduction
11.19.4 Zhejiang Hisun Pharmaceuticals Revenue in Pharmaceutical Contract Manufacture Organization Business (2020-2025)
11.19.5 Zhejiang Hisun Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Lonza
Boehringer Ingelheim
Catalent
Baxter
AbbVie
Pfizer Inc
Evonik
Fareva Group
Aenova
ALMAC
Delpharm
Recipharm
Aesica
Nipro Corporation
Daito Pharmaceutical
Teva API
Esteve Quimica
Euticals
Zhejiang Hisun Pharmaceuticals
List of Tables
 Table 1. Global Pharmaceutical Contract Manufacture Organization Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Active Pharmaceutical Ingredients (APIs)
 Table 3. Key Players of Finished Dose Formulations (FDFs)
 Table 4. Global Pharmaceutical Contract Manufacture Organization Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Pharmaceutical Contract Manufacture Organization Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Pharmaceutical Contract Manufacture Organization Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Pharmaceutical Contract Manufacture Organization Market Share by Region (2020-2025)
 Table 8. Global Pharmaceutical Contract Manufacture Organization Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Pharmaceutical Contract Manufacture Organization Market Share by Region (2026-2031)
 Table 10. Pharmaceutical Contract Manufacture Organization Market Trends
 Table 11. Pharmaceutical Contract Manufacture Organization Market Drivers
 Table 12. Pharmaceutical Contract Manufacture Organization Market Challenges
 Table 13. Pharmaceutical Contract Manufacture Organization Market Restraints
 Table 14. Global Pharmaceutical Contract Manufacture Organization Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Pharmaceutical Contract Manufacture Organization Market Share by Players (2020-2025)
 Table 16. Global Top Pharmaceutical Contract Manufacture Organization Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Contract Manufacture Organization as of 2024)
 Table 17. Ranking of Global Top Pharmaceutical Contract Manufacture Organization Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Pharmaceutical Contract Manufacture Organization Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Pharmaceutical Contract Manufacture Organization, Headquarters and Area Served
 Table 20. Global Key Players of Pharmaceutical Contract Manufacture Organization, Product and Application
 Table 21. Global Key Players of Pharmaceutical Contract Manufacture Organization, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Pharmaceutical Contract Manufacture Organization Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Pharmaceutical Contract Manufacture Organization Revenue Market Share by Type (2020-2025)
 Table 25. Global Pharmaceutical Contract Manufacture Organization Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Pharmaceutical Contract Manufacture Organization Revenue Market Share by Type (2026-2031)
 Table 27. Global Pharmaceutical Contract Manufacture Organization Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Pharmaceutical Contract Manufacture Organization Revenue Market Share by Application (2020-2025)
 Table 29. Global Pharmaceutical Contract Manufacture Organization Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Pharmaceutical Contract Manufacture Organization Revenue Market Share by Application (2026-2031)
 Table 31. North America Pharmaceutical Contract Manufacture Organization Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Pharmaceutical Contract Manufacture Organization Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Pharmaceutical Contract Manufacture Organization Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Pharmaceutical Contract Manufacture Organization Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Pharmaceutical Contract Manufacture Organization Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Pharmaceutical Contract Manufacture Organization Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Pharmaceutical Contract Manufacture Organization Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Pharmaceutical Contract Manufacture Organization Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Pharmaceutical Contract Manufacture Organization Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pharmaceutical Contract Manufacture Organization Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Pharmaceutical Contract Manufacture Organization Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Pharmaceutical Contract Manufacture Organization Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Pharmaceutical Contract Manufacture Organization Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Pharmaceutical Contract Manufacture Organization Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Pharmaceutical Contract Manufacture Organization Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Lonza Company Details
 Table 47. Lonza Business Overview
 Table 48. Lonza Pharmaceutical Contract Manufacture Organization Product
 Table 49. Lonza Revenue in Pharmaceutical Contract Manufacture Organization Business (2020-2025) & (US$ Million)
 Table 50. Lonza Recent Development
 Table 51. Boehringer Ingelheim Company Details
 Table 52. Boehringer Ingelheim Business Overview
 Table 53. Boehringer Ingelheim Pharmaceutical Contract Manufacture Organization Product
 Table 54. Boehringer Ingelheim Revenue in Pharmaceutical Contract Manufacture Organization Business (2020-2025) & (US$ Million)
 Table 55. Boehringer Ingelheim Recent Development
 Table 56. Catalent Company Details
 Table 57. Catalent Business Overview
 Table 58. Catalent Pharmaceutical Contract Manufacture Organization Product
 Table 59. Catalent Revenue in Pharmaceutical Contract Manufacture Organization Business (2020-2025) & (US$ Million)
 Table 60. Catalent Recent Development
 Table 61. Baxter Company Details
 Table 62. Baxter Business Overview
 Table 63. Baxter Pharmaceutical Contract Manufacture Organization Product
 Table 64. Baxter Revenue in Pharmaceutical Contract Manufacture Organization Business (2020-2025) & (US$ Million)
 Table 65. Baxter Recent Development
 Table 66. AbbVie Company Details
 Table 67. AbbVie Business Overview
 Table 68. AbbVie Pharmaceutical Contract Manufacture Organization Product
 Table 69. AbbVie Revenue in Pharmaceutical Contract Manufacture Organization Business (2020-2025) & (US$ Million)
 Table 70. AbbVie Recent Development
 Table 71. Pfizer Company Details
 Table 72. Pfizer Business Overview
 Table 73. Pfizer Pharmaceutical Contract Manufacture Organization Product
 Table 74. Pfizer Revenue in Pharmaceutical Contract Manufacture Organization Business (2020-2025) & (US$ Million)
 Table 75. Pfizer Recent Development
 Table 76. Evonik Company Details
 Table 77. Evonik Business Overview
 Table 78. Evonik Pharmaceutical Contract Manufacture Organization Product
 Table 79. Evonik Revenue in Pharmaceutical Contract Manufacture Organization Business (2020-2025) & (US$ Million)
 Table 80. Evonik Recent Development
 Table 81. Fareva group Company Details
 Table 82. Fareva group Business Overview
 Table 83. Fareva group Pharmaceutical Contract Manufacture Organization Product
 Table 84. Fareva group Revenue in Pharmaceutical Contract Manufacture Organization Business (2020-2025) & (US$ Million)
 Table 85. Fareva group Recent Development
 Table 86. Aenova Company Details
 Table 87. Aenova Business Overview
 Table 88. Aenova Pharmaceutical Contract Manufacture Organization Product
 Table 89. Aenova Revenue in Pharmaceutical Contract Manufacture Organization Business (2020-2025) & (US$ Million)
 Table 90. Aenova Recent Development
 Table 91. Almac Company Details
 Table 92. Almac Business Overview
 Table 93. Almac Pharmaceutical Contract Manufacture Organization Product
 Table 94. Almac Revenue in Pharmaceutical Contract Manufacture Organization Business (2020-2025) & (US$ Million)
 Table 95. Almac Recent Development
 Table 96. Delpharm Company Details
 Table 97. Delpharm Business Overview
 Table 98. Delpharm Pharmaceutical Contract Manufacture Organization Product
 Table 99. Delpharm Revenue in Pharmaceutical Contract Manufacture Organization Business (2020-2025) & (US$ Million)
 Table 100. Delpharm Recent Development
 Table 101. Recipharm Company Details
 Table 102. Recipharm Business Overview
 Table 103. Recipharm Pharmaceutical Contract Manufacture Organization Product
 Table 104. Recipharm Revenue in Pharmaceutical Contract Manufacture Organization Business (2020-2025) & (US$ Million)
 Table 105. Recipharm Recent Development
 Table 106. Aesica Company Details
 Table 107. Aesica Business Overview
 Table 108. Aesica Pharmaceutical Contract Manufacture Organization Product
 Table 109. Aesica Revenue in Pharmaceutical Contract Manufacture Organization Business (2020-2025) & (US$ Million)
 Table 110. Aesica Recent Development
 Table 111. NIPRO CORPORATION Company Details
 Table 112. NIPRO CORPORATION Business Overview
 Table 113. NIPRO CORPORATION Pharmaceutical Contract Manufacture Organization Product
 Table 114. NIPRO CORPORATION Revenue in Pharmaceutical Contract Manufacture Organization Business (2020-2025) & (US$ Million)
 Table 115. NIPRO CORPORATION Recent Development
 Table 116. Daito Pharmaceutical Company Details
 Table 117. Daito Pharmaceutical Business Overview
 Table 118. Daito Pharmaceutical Pharmaceutical Contract Manufacture Organization Product
 Table 119. Daito Pharmaceutical Revenue in Pharmaceutical Contract Manufacture Organization Business (2020-2025) & (US$ Million)
 Table 120. Daito Pharmaceutical Recent Development
 Table 121. Teva API Company Details
 Table 122. Teva API Business Overview
 Table 123. Teva API Pharmaceutical Contract Manufacture Organization Product
 Table 124. Teva API Revenue in Pharmaceutical Contract Manufacture Organization Business (2020-2025) & (US$ Million)
 Table 125. Teva API Recent Development
 Table 126. Esteve Quimica Company Details
 Table 127. Esteve Quimica Business Overview
 Table 128. Esteve Quimica Pharmaceutical Contract Manufacture Organization Product
 Table 129. Esteve Quimica Revenue in Pharmaceutical Contract Manufacture Organization Business (2020-2025) & (US$ Million)
 Table 130. Esteve Quimica Recent Development
 Table 131. Euticals Company Details
 Table 132. Euticals Business Overview
 Table 133. Euticals Pharmaceutical Contract Manufacture Organization Product
 Table 134. Euticals Revenue in Pharmaceutical Contract Manufacture Organization Business (2020-2025) & (US$ Million)
 Table 135. Euticals Recent Development
 Table 136. Zhejiang Hisun Pharmaceuticals Company Details
 Table 137. Zhejiang Hisun Pharmaceuticals Business Overview
 Table 138. Zhejiang Hisun Pharmaceuticals Pharmaceutical Contract Manufacture Organization Product
 Table 139. Zhejiang Hisun Pharmaceuticals Revenue in Pharmaceutical Contract Manufacture Organization Business (2020-2025) & (US$ Million)
 Table 140. Zhejiang Hisun Pharmaceuticals Recent Development
 Table 141. Research Programs/Design for This Report
 Table 142. Key Data Information from Secondary Sources
 Table 143. Key Data Information from Primary Sources
 Table 144. Authors List of This Report


List of Figures
 Figure 1. Pharmaceutical Contract Manufacture Organization Picture
 Figure 2. Global Pharmaceutical Contract Manufacture Organization Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pharmaceutical Contract Manufacture Organization Market Share by Type: 2024 VS 2031
 Figure 4. Active Pharmaceutical Ingredients (APIs) Features
 Figure 5. Finished Dose Formulations (FDFs) Features
 Figure 6. Global Pharmaceutical Contract Manufacture Organization Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Pharmaceutical Contract Manufacture Organization Market Share by Application: 2024 VS 2031
 Figure 8. Specialty/Midsize Case Studies
 Figure 9. Generics Case Studies
 Figure 10. Big Pharma Case Studies
 Figure 11. Others Case Studies
 Figure 12. Pharmaceutical Contract Manufacture Organization Report Years Considered
 Figure 13. Global Pharmaceutical Contract Manufacture Organization Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Pharmaceutical Contract Manufacture Organization Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Pharmaceutical Contract Manufacture Organization Market Share by Region: 2024 VS 2031
 Figure 16. Global Pharmaceutical Contract Manufacture Organization Market Share by Players in 2024
 Figure 17. Global Top Pharmaceutical Contract Manufacture Organization Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Contract Manufacture Organization as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Pharmaceutical Contract Manufacture Organization Revenue in 2024
 Figure 19. North America Pharmaceutical Contract Manufacture Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Pharmaceutical Contract Manufacture Organization Market Share by Country (2020-2031)
 Figure 21. United States Pharmaceutical Contract Manufacture Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Pharmaceutical Contract Manufacture Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Pharmaceutical Contract Manufacture Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Pharmaceutical Contract Manufacture Organization Market Share by Country (2020-2031)
 Figure 25. Germany Pharmaceutical Contract Manufacture Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Pharmaceutical Contract Manufacture Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Pharmaceutical Contract Manufacture Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Pharmaceutical Contract Manufacture Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Pharmaceutical Contract Manufacture Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Pharmaceutical Contract Manufacture Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Pharmaceutical Contract Manufacture Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Pharmaceutical Contract Manufacture Organization Market Share by Region (2020-2031)
 Figure 33. China Pharmaceutical Contract Manufacture Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Pharmaceutical Contract Manufacture Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Pharmaceutical Contract Manufacture Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Pharmaceutical Contract Manufacture Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Pharmaceutical Contract Manufacture Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Pharmaceutical Contract Manufacture Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Pharmaceutical Contract Manufacture Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Pharmaceutical Contract Manufacture Organization Market Share by Country (2020-2031)
 Figure 41. Mexico Pharmaceutical Contract Manufacture Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Pharmaceutical Contract Manufacture Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Pharmaceutical Contract Manufacture Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Pharmaceutical Contract Manufacture Organization Market Share by Country (2020-2031)
 Figure 45. Turkey Pharmaceutical Contract Manufacture Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Pharmaceutical Contract Manufacture Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Pharmaceutical Contract Manufacture Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Lonza Revenue Growth Rate in Pharmaceutical Contract Manufacture Organization Business (2020-2025)
 Figure 49. Boehringer Ingelheim Revenue Growth Rate in Pharmaceutical Contract Manufacture Organization Business (2020-2025)
 Figure 50. Catalent Revenue Growth Rate in Pharmaceutical Contract Manufacture Organization Business (2020-2025)
 Figure 51. Baxter Revenue Growth Rate in Pharmaceutical Contract Manufacture Organization Business (2020-2025)
 Figure 52. AbbVie Revenue Growth Rate in Pharmaceutical Contract Manufacture Organization Business (2020-2025)
 Figure 53. Pfizer Revenue Growth Rate in Pharmaceutical Contract Manufacture Organization Business (2020-2025)
 Figure 54. Evonik Revenue Growth Rate in Pharmaceutical Contract Manufacture Organization Business (2020-2025)
 Figure 55. Fareva group Revenue Growth Rate in Pharmaceutical Contract Manufacture Organization Business (2020-2025)
 Figure 56. Aenova Revenue Growth Rate in Pharmaceutical Contract Manufacture Organization Business (2020-2025)
 Figure 57. Almac Revenue Growth Rate in Pharmaceutical Contract Manufacture Organization Business (2020-2025)
 Figure 58. Delpharm Revenue Growth Rate in Pharmaceutical Contract Manufacture Organization Business (2020-2025)
 Figure 59. Recipharm Revenue Growth Rate in Pharmaceutical Contract Manufacture Organization Business (2020-2025)
 Figure 60. Aesica Revenue Growth Rate in Pharmaceutical Contract Manufacture Organization Business (2020-2025)
 Figure 61. NIPRO CORPORATION Revenue Growth Rate in Pharmaceutical Contract Manufacture Organization Business (2020-2025)
 Figure 62. Daito Pharmaceutical Revenue Growth Rate in Pharmaceutical Contract Manufacture Organization Business (2020-2025)
 Figure 63. Teva API Revenue Growth Rate in Pharmaceutical Contract Manufacture Organization Business (2020-2025)
 Figure 64. Esteve Quimica Revenue Growth Rate in Pharmaceutical Contract Manufacture Organization Business (2020-2025)
 Figure 65. Euticals Revenue Growth Rate in Pharmaceutical Contract Manufacture Organization Business (2020-2025)
 Figure 66. Zhejiang Hisun Pharmaceuticals Revenue Growth Rate in Pharmaceutical Contract Manufacture Organization Business (2020-2025)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions